KEGG   COMPOUND: C00704
Entry
C00704                      Compound                               
Name
Superoxide;
O2.-;
Superoxide anion;
O2-
Formula
O2
Exact mass
31.9898
Mol weight
32.00
Structure
Reaction
R00275 R02670 R05743 R12508
Pathway
map04066  HIF-1 signaling pathway
map04212  Longevity regulating pathway - worm
map04613  Neutrophil extracellular trap formation
map04626  Plant-pathogen interaction
map04940  Type I diabetes mellitus
map05010  Alzheimer disease
map05012  Parkinson disease
map05014  Amyotrophic lateral sclerosis
map05020  Prion disease
map05022  Pathways of neurodegeneration - multiple diseases
map05171  Coronavirus disease - COVID-19
map05200  Pathways in cancer
map05208  Chemical carcinogenesis - reactive oxygen species
map05225  Hepatocellular carcinoma
map05230  Central carbon metabolism in cancer
map05415  Diabetic cardiomyopathy
map05417  Lipid and atherosclerosis
map05418  Fluid shear stress and atherosclerosis
Network
nt06171  SARS coronavirus 2 (SARS-CoV-2)
nt06226  KEAP1-NRF2 signaling (cancer)
nt06251  CYP-mediated ROS formation (cancer)
nt06253  Antioxidant system (cancer)
nt06263  Hepatocellular carcinoma
nt06463  Parkinson disease
nt06465  Prion disease
Enzyme
1.10.3.17       1.11.1.6        1.11.1.21       1.15.1.1        
1.15.1.2
Other DBs
CAS: 11062-77-4
PubChem: 3971
ChEBI: 18421
LinkDB
KCF data

ATOM        2
            1   O1a O    21.4200  -16.1700 #-
            2   O1a O    22.8200  -16.1700 #^
BOND        1
            1     1   2 1

» Japanese version

KEGG   COMPOUND: C00027
Entry
C00027                      Compound                               
Name
Hydrogen peroxide;
H2O2;
Oxydol
Formula
H2O2
Exact mass
34.0055
Mol weight
34.01
Structure
Remark
Same as: D00008
Reaction
R00009 R00011 R00017 R00033 R00052 R00057 R00069 R00072
R00090 R00113 R00120 R00207 R00211 R00250 R00273 R00274
R00275 R00277 R00278 R00279 R00302 R00357 R00359 R00360
R00366 R00388 R00447 R00466 R00475 R00481 R00533 R00602
R00608 R00610 R00612 R00635 R00637 R00643 R00644 R00648
R00677 R00689 R00729 R00799 R00846 R00975 R00993 R01022
R01098 R01099 R01151 R01203 R01259 R01264 R01340 R01341
R01442 R01459 R01469 R01489 R01491 R01522 R01564 R01609
R01695 R01703 R01709 R01710 R01711 R01769 R01851 R01853
R01910 R01914 R01962 R02106 R02107 R02125 R02132 R02150
R02173 R02197 R02204 R02233 R02277 R02373 R02382 R02457
R02529 R02532 R02613 R02657 R02666 R02670 R02673 R02681
R02715 R02810 R02877 R02880 R02894 R02908 R02919 R02923
R03135 R03139 R03184 R03202 R03208 R03222 R03532 R03722
R03736 R03831 R03871 R03899 R03953 R04025 R04027 R04048
R04085 R04178 R04221 R04239 R04248 R04300 R04461 R04674
R04703 R04706 R04768 R04890 R04893 R04894 R04904 R04907
R04908 R05317 R05334 R05695 R05696 R05697 R05698 R05743
R05861 R05862 R05863 R06124 R06154 R06244 R06633 R06740
R06924 R06957 R07151 R07152 R07170 R07171 R07172 R07221
R07353 R07360 R07400 R07401 R07415 R07463 R07598 R07612
R07934 R07942 R07948 R07950 R07977 R07978 R07979 R07981
R08211 R08212 R08235 R08346 R08347 R08348 R08349 R08384
R08408 R08522 R08523 R08702 R08795 R08863 R08896 R08902
R09074 R09075 R09076 R09077 R09334 R09335 R09495 R09505
R09507 R09540 R09560 R09562 R09563 R09564 R09740 R09741
R09807 R10053 R10101 R10102 R10160 R10207 R10212 R10216
R10327 R10328 R10329 R10388 R10389 R10635 R10636 R10721
R10853 R10855 R10857 R10858 R10915 R11048 R11050 R11119
R11267 R11268 R11273 R11284 R11351 R11352 R11354 R11380
R11381 R11394 R11489 R11490 R11491 R11492 R11501 R11502
R11503 R11504 R11505 R11522 R11570 R11572 R11573 R11575
R11577 R11604 R11618 R11620 R11748 R11906 R11916 R11917
R11918 R11996 R12101 R12356 R12420 R12454 R12455 R12611
R12684 R12685 R12966 R12967 R12973 R12975 R12976 R12989
R12990 R13024 R13026 R13027 R13033 R13138 R13139 R13141
R13251 R13252 R13285 R13344 R13384 R13389
 » show all
Pathway
map00630  Glyoxylate and dicarboxylate metabolism
map01110  Biosynthesis of secondary metabolites
map04022  cGMP-PKG signaling pathway
map04210  Apoptosis
map04216  Ferroptosis
map04217  Necroptosis
map04218  Cellular senescence
map04380  Osteoclast differentiation
map04613  Neutrophil extracellular trap formation
map04624  Toll and Imd signaling pathway
map04625  C-type lectin receptor signaling pathway
map04626  Plant-pathogen interaction
map04670  Leukocyte transendothelial migration
map04918  Thyroid hormone synthesis
map04940  Type I diabetes mellitus
map05010  Alzheimer disease
map05012  Parkinson disease
map05014  Amyotrophic lateral sclerosis
map05020  Prion disease
map05022  Pathways of neurodegeneration - multiple diseases
map05030  Cocaine addiction
map05031  Amphetamine addiction
map05034  Alcoholism
map05146  Amoebiasis
map05164  Influenza A
map05166  Human T-cell leukemia virus 1 infection
map05171  Coronavirus disease - COVID-19
map05200  Pathways in cancer
map05204  Chemical carcinogenesis - DNA adducts
map05208  Chemical carcinogenesis - reactive oxygen species
map05225  Hepatocellular carcinoma
map05322  Systemic lupus erythematosus
map05415  Diabetic cardiomyopathy
map05417  Lipid and atherosclerosis
Module
M00532  Photorespiration
Network
nt06171  SARS coronavirus 2 (SARS-CoV-2)
nt06226  KEAP1-NRF2 signaling (cancer)
nt06251  CYP-mediated ROS formation (cancer)
nt06263  Hepatocellular carcinoma
nt06322  TRH-TSH-TH signaling
nt06463  Parkinson disease
nt06465  Prion disease
Enzyme
1.1.3.2         1.1.3.4         1.1.3.5         1.1.3.6         
1.1.3.7         1.1.3.8         1.1.3.9         1.1.3.10        
1.1.3.11        1.1.3.12        1.1.3.13        1.1.3.15        
1.1.3.16        1.1.3.17        1.1.3.18        1.1.3.19        
1.1.3.21        1.1.3.23        1.1.3.27        1.1.3.29        
1.1.3.30        1.1.3.37        1.1.3.38        1.1.3.39        
1.1.3.40        1.1.3.41        1.1.3.42        1.1.3.43        
1.1.3.44        1.1.3.45        1.1.3.46        1.1.3.47        
1.1.3.48        1.1.3.49        1.1.3.50        1.1.3.-         
1.1.5.4         1.1.99.9        1.1.99.18       1.2.3.1         
1.2.3.3         1.2.3.4         1.2.3.5         1.2.3.6         
1.2.3.7         1.2.3.8         1.2.3.9         1.2.3.14        
1.2.3.15        1.2.3.-         1.3.3.4         1.3.3.6         
1.3.3.7         1.3.3.8         1.3.3.10        1.3.3.11        
1.3.3.12        1.3.3.13        1.3.3.14        1.3.3.15        
1.3.3.17        1.3.98.5        1.4.3.1         1.4.3.2         
1.4.3.3         1.4.3.4         1.4.3.5         1.4.3.7         
1.4.3.8         1.4.3.10        1.4.3.11        1.4.3.12        
1.4.3.13        1.4.3.14        1.4.3.15        1.4.3.16        
1.4.3.19        1.4.3.20        1.4.3.21        1.4.3.22        
1.4.3.23        1.4.3.25        1.4.3.26        1.4.3.27        
1.4.3.-         1.4.9.2         1.5.3.1         1.5.3.2         
1.5.3.4         1.5.3.5         1.5.3.6         1.5.3.7         
1.5.3.10        1.5.3.12        1.5.3.13        1.5.3.14        
1.5.3.15        1.5.3.16        1.5.3.17        1.5.3.18        
1.5.3.19        1.5.3.21        1.5.3.24        1.5.3.25        
1.5.3.26        1.5.3.27        1.5.3.-         1.5.99.6        
1.6.3.1         1.6.3.3         1.6.3.5         1.7.3.1         
1.7.3.3         1.7.3.5         1.8.3.1         1.8.3.2         
1.8.3.3         1.8.3.4         1.8.3.5         1.8.3.6         
1.10.3.5        1.10.3.6        1.10.3.16       1.11.1.1        
1.11.1.2        1.11.1.3        1.11.1.5        1.11.1.6        
1.11.1.7        1.11.1.8        1.11.1.9        1.11.1.10       
1.11.1.11       1.11.1.13       1.11.1.14       1.11.1.16       
1.11.1.17       1.11.1.18       1.11.1.19       1.11.1.21       
1.11.1.23       1.11.2.1        1.11.2.2        1.11.2.4        
1.11.2.5        1.11.2.6        1.14.13.-       1.15.1.1        
1.15.1.2        1.16.3.2        1.17.3.2        1.17.3.3        
1.17.3.5        1.21.3.3        1.21.3.7        1.21.3.8        
1.21.3.11       4.1.1.107       4.1.1.108       4.1.1.109       
4.99.1.-
 » show all
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A01 STOMATOLOGICAL PREPARATIONS
   A01A STOMATOLOGICAL PREPARATIONS
    A01AB Antiinfectives and antiseptics for local oral treatment
     A01AB02 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
 D DERMATOLOGICALS
  D08 ANTISEPTICS AND DISINFECTANTS
   D08A ANTISEPTICS AND DISINFECTANTS
    D08AX Other antiseptics and disinfectants
     D08AX01 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
  D11 OTHER DERMATOLOGICAL PREPARATIONS
   D11A OTHER DERMATOLOGICAL PREPARATIONS
    D11AX Other dermatologicals
     D11AX25 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
 S SENSORY ORGANS
  S02 OTOLOGICALS
   S02A ANTIINFECTIVES
    S02AA Antiinfectives
     S02AA06 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  26  Epidermides
   261  Antimicrobial agents
    2614  Peroxides
     D00008  Hydrogen peroxide (USP); Oxydol (JP18)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for integumentary system
  54 Disinfectants (incl. special bandages)
   D00008  Hydrogen peroxide (USP)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   Oxydol
    D00008  Hydrogen peroxide (USP)
Animal drugs in Japan [BR:br08331]
 95  Agents for external use
  954  Anti-dermoinfectives
   9549  Other anti-dermoinfectives
    C00027  Hydrogen peroxide
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00008  Oxydol
Other DBs
CAS: 7722-84-1
PubChem: 3329
ChEBI: 16240
PDB-CCD: PEO[PDBj]
NIKKAJI: J98.262H
LinkDB
KCF data

ATOM        2
            1   O1a O    29.6100  -14.4200
            2   O1a O    31.0100  -14.4200
BOND        1
            1     1   2 1

» Japanese version

KEGG   COMPOUND: C16845
Entry
C16845                      Compound                               
Name
Peroxynitrite
Formula
NO3
Exact mass
61.9878
Mol weight
62.01
Structure
Pathway
map04071  Sphingolipid signaling pathway
map05010  Alzheimer disease
map05014  Amyotrophic lateral sclerosis
map05022  Pathways of neurodegeneration - multiple diseases
map05418  Fluid shear stress and atherosclerosis
Other DBs
CAS: 19059-14-4
PubChem: 96023369
ChEBI: 25941
NIKKAJI: J672.821I
LinkDB
KCF data

ATOM        4
            1   N2b N    29.5101  -22.9654
            2   O2a O    28.3437  -22.2723
            3   O3a O    30.7638  -22.2504
            4   O1a O    27.0626  -23.1613 #-
BOND        3
            1     1   2 1
            2     1   3 2
            3     2   4 1

» Japanese version

KEGG   COMPOUND: C16844
Entry
C16844                      Compound                               
Name
Hydroxyl radical;
Hydrogen oxide
Formula
OH
Exact mass
17.0027
Mol weight
17.01
Structure
Pathway
map04216  Ferroptosis
map04217  Necroptosis
map04218  Cellular senescence
map04625  C-type lectin receptor signaling pathway
map04626  Plant-pathogen interaction
map05012  Parkinson disease
map05014  Amyotrophic lateral sclerosis
map05022  Pathways of neurodegeneration - multiple diseases
map05200  Pathways in cancer
map05204  Chemical carcinogenesis - DNA adducts
map05208  Chemical carcinogenesis - reactive oxygen species
map05225  Hepatocellular carcinoma
map05415  Diabetic cardiomyopathy
Network
nt06226  KEAP1-NRF2 signaling (cancer)
nt06251  CYP-mediated ROS formation (cancer)
nt06263  Hepatocellular carcinoma
nt06463  Parkinson disease
Other DBs
CAS: 3352-57-6
PubChem: 96023368
ChEBI: 29191
NIKKAJI: J209.359F
LinkDB
KCF data

ATOM        1
            1   O0  O     5.7859   -6.1050
BOND        0

» Japanese version

DBGET integrated database retrieval system